Related Experiment Video
Updated: Jun 21, 2026
06:27
Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
Published on: May 6, 2013
Update on nonautoimmune diabetes in children
1University of Colorado Denver, Aurora, Colorado 80045, USA. Phil.Zeitler@ucdenver.edu
The Journal of Clinical Endocrinology and Metabolism
|July 9, 2009
Summary
Type 2 diabetes mellitus (T2DM) in adolescents is a growing concern, yet research remains limited. Understanding its unique epidemiology and pathophysiology is crucial for effective prevention and treatment strategies.
Area of Science:
- Pediatrics
- Endocrinology
- Public Health
Background:
- Nonautoimmune-mediated type 2 diabetes mellitus (T2DM) is increasingly prevalent in adolescents.
- Research on adolescent T2DM is limited, complicated by diagnostic challenges and overlapping diabetes types.
- Unique pathophysiological aspects in adolescents are suggested by diagnostic ratios and puberty onset.
Purpose of the Study:
- To highlight the growing importance and research gaps in adolescent T2DM.
- To discuss the complexities in understanding the epidemiology and pathophysiology of T2DM in this age group.
- To emphasize the need for tailored prevention and treatment strategies.
Main Methods:
- Review of current understanding of adolescent T2DM epidemiology and pathophysiology.
- Identification of research challenges and emerging areas of investigation.
- Discussion of clinical study needs and guideline development.
Main Results:
- Adolescent T2DM presents unique epidemiological and pathophysiological features.
- Factors like intrauterine development and puberty influence T2DM onset in youth.
- Ongoing research is exploring prevention, treatment, and long-term outcomes.
Conclusions:
- Adolescent T2DM requires focused research attention due to its increasing prevalence and public health implications.
- Further studies are critical for developing effective screening, prevention, and treatment guidelines.
- Understanding medium- and long-term morbidity is essential for managing early-onset T2DM.
Related Concept Videos
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...